"Model t" cells: a time-tested vehicle for gene therapy

Area of Science:

• Immunology
• Cell Biology
• Gene Therapy

Background:

• T lymphocytes have been engineered with foreign genes for over 20 years.
• Advances in genomic analysis have deepened understanding of T cell diversity, function, and therapeutic applications.
• Mouse models have elucidated genes crucial for T cell antigen recognition and immune response regulation.

Purpose of the Study:

• To review strategies for engineering T cells with enhanced therapeutic capabilities.
• To explore the introduction of specific genes to control T cell functions for disease treatment.

Main Methods:

• Review of scientific literature on T cell gene therapy and genomic analysis.
• Discussion of strategies for introducing genes that control cytokine secretion, T cell receptor specificity, and surface molecule expression.
• Exploration of chimeric antigen receptors for MHC-independent antigen recognition.

Main Results:

• Knowledge of T cell gene function enables the design of lymphocytes targeting viral, bacterial, fungal, parasitic, and tumor antigens.
• Engineered T cells can be designed to regulate autoimmune and inflammatory responses by targeting self-antigens.
• Strategies focus on controlling cytokine secretion, T cell receptor specificity, chimeric antigen receptors, co-stimulatory/inhibitory molecules, and single-gene factors.

Conclusions:

• Genetic engineering offers powerful strategies to design T cells for diverse therapeutic applications.
• The precise control of T cell functions through gene introduction holds significant promise for treating infectious diseases, cancer, and autoimmune conditions.